Dedhiya; Mahendra

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dedhiya; Mahendra.The latest application filed is for "stable formulations of linaclotide".

Company Profile

5.6.26

Dedhiya; Mahendra - Pomona NY
Dedhiya, Mahendra - Dublin OH
Dedhiya, Mahendra - Nanuet NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Stable Formulations of Linaclotide App 20220233635 - Mo; Yun ; et al.	2022-07-28
Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration App 20220125734 - Fretzen; Angelika ; et al.	2022-04-28
Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration App 20210290554 - Fretzen; Angelika ; et al.	2021-09-23
Stable formulations of linaclotide Grant 10,702,576 - Mo , et al.	2020-07-07
Stable formulations of linaclotide Grant 10,675,325 - Mo , et al.	2020-06-09
Stable Formulations of Linaclotide App 20200030407 - MO; YUN ; et al.	2020-01-30
Stable Formulations of Linaclotide App 20200009216 - Mo; Yun ; et al.	2020-01-09
Stable Formulations of Linaclotide App 20190209644 - Mo; Yun ; et al.	2019-07-11
Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration App 20190029967 - Fretzen; Angelika ; et al.	2019-01-31
Delayed Release Compositions of Linaclotide App 20160310559 - Fretzen; Angelika ; et al.	2016-10-27
Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration App 20150132375 - Fretzen; Angelika ; et al.	2015-05-14
Orally Disintegrating Compositions of Linaclotide App 20150031632 - MO; YUN ; et al.	2015-01-29
Stable Formulations of Linaclotide App 20140378393 - Mo; Yun ; et al.	2014-12-25
Treatment of Chronic Constipation App 20140349948 - Johnston; Jeffrey ; et al.	2014-11-27
Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration App 20140287034 - Fretzen; Angelika ; et al.	2014-09-25
Stable solid formulation of a GC-C receptor agonist polypeptide suitable for oral administration Grant 8,802,628 - Fretzen , et al. August 12, 2	2014-08-12
Formulations comprising linaclotide Grant 8,748,573 - Fretzen , et al. June 10, 2	2014-06-10
Treatments Of Gastrointestinal Disorders App 20140005128 - Mo; Yun ; et al.	2014-01-02
Stable Solid Formulation of GC-C Receptor Agonist Polypeptide Suitable for Oral Administration App 20130273169 - Fretzen; Angelika ; et al.	2013-10-17
Formulations Comprising Linaclotide App 20130190239 - FRETZEN; ANGELIKA ; et al.	2013-07-25
Linaclotide for the Treatment of Chronic Constipation App 20130059797 - Johnston; Jeffrey ; et al.	2013-03-07
Orally Disintegrating Compositions of Linaclotide App 20130012454 - Mo; Yun ; et al.	2013-01-10
Stable Solid Formulation of a GC-C Receptor Agonist Polypeptide Suitable for Oral Administration App 20120213846 - Fretzen; Angelika ; et al.	2012-08-23
Formulations Comprising Linaclotide App 20110059903 - Fretzen; Angelika ; et al.	2011-03-10
Stable Solid Formulation of A GC-C Receptor Agonist Polypeptide Suitable for Oral Administration App 20100048489 - Fretzen; Angelika ; et al.	2010-02-25
Soluble Dosage Forms Containing Cephem Derivatives Suitable For Parenteral Administration App 20090082326 - Dedhiya; Mahendra ; et al.	2009-03-26
Fluticasone suspension formulation, spray pattern method, and nasal spray apparatus App 20020132803 - Dedhiya, Mahendra ; et al.	2002-09-19
Megestrol acetate suspension App 20020028794 - Brubaker, Greg Allen ; et al.	2002-03-07

Company Registrations

SEC

0001644912

Dedhiya Mahendra

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.